➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Baxter
Moodys
Harvard Business School
Mallinckrodt

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

TETRABENAZINE Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Tetrabenazine, and when can generic versions of Tetrabenazine launch?

Tetrabenazine is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Apotex, Bionpharma Inc, Dr Reddys, Hetero Labs Ltd V, Hikma, Lupin Ltd, Mylan, Piramal Hlthcare Uk, and Sun Pharm. and is included in eleven NDAs.

The generic ingredient in TETRABENAZINE is tetrabenazine. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tetrabenazine

A generic version of TETRABENAZINE was approved as tetrabenazine by SUN PHARM on August 17th, 2015.

  Get Started Free

Drug patent expirations by year for TETRABENAZINE
Drug Prices for TETRABENAZINE

See drug prices for TETRABENAZINE

Recent Clinical Trials for TETRABENAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kirk A. FreyPhase 1
Adeptio PharmaceuticalsPhase 1
Dr. Reddy's Laboratories LimitedPhase 1

See all TETRABENAZINE clinical trials

Pharmacology for TETRABENAZINE
Medical Subject Heading (MeSH) Categories for TETRABENAZINE

US Patents and Regulatory Information for TETRABENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc TETRABENAZINE tetrabenazine TABLET;ORAL 206686-001 Jul 7, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Piramal Hlthcare Uk TETRABENAZINE tetrabenazine TABLET;ORAL 213316-001 Jan 22, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Bionpharma Inc TETRABENAZINE tetrabenazine TABLET;ORAL 208826-002 Dec 18, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Apotex TETRABENAZINE tetrabenazine TABLET;ORAL 206093-001 Mar 17, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Hikma TETRABENAZINE tetrabenazine TABLET;ORAL 209739-001 Apr 8, 2019 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Sun Pharm TETRABENAZINE tetrabenazine TABLET;ORAL 206129-001 Aug 17, 2015 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Dr Reddys TETRABENAZINE tetrabenazine TABLET;ORAL 209284-001 Jan 8, 2018 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Colorcon
Merck
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.